Skip to main content
. 2016 Sep 6;15(1):455. doi: 10.1186/s12936-016-1444-x

Fig. 4.

Fig. 4

Kaplan–Meier survival estimates PCR-unadjusted. Treatment efficacy for ASAQ and AL was 85.3 and 92.1 % at day 28 (p = 0.0933), and 77.7 and 84.5 % at day 42 (p = 0.1605), respectively